EcoDrugPlus

Dopamine Receptor D4

Ensembl ID : ENSPPRG00000004803
Gene Symbol: DRD4
4 Cross references
246 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSPPRG00000017900
Gene Symbol: DRD5
4 Cross references
186 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSPPRG00000024856
Gene Symbol: ENPP2
4 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSPPRG00000013135
Gene Symbol: EGLN1
3 Cross references
227 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 2

Ensembl ID : ENSPPRG00000021272
Gene Symbol: EGLN2
4 Cross references
190 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSPPRG00000009618
Gene Symbol: EGLN3
4 Cross references
207 Possible Orthologues:

Elastase, Neutrophil Expressed

Ensembl ID : ENSPPRG00000007549
Gene Symbol: ELANE
3 Cross references
102 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSPPRG00000002429
Gene Symbol: EPAS1
3 Cross references
222 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSPPRG00000007734
Gene Symbol: ECE1
4 Cross references
229 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSPPRG00000007364
Gene Symbol: EDNRA
4 Cross references
265 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSPPRG00000018672
Gene Symbol: EDNRB
4 Cross references
264 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSPPRG00000021506
Gene Symbol: EZH2
4 Cross references
222 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).